Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro
- Ricardo Ribeiro1, 2, 3, 13Email author,
- Cátia Monteiro1, 3,
- Virgínia Cunha1, 3,
- Maria José Oliveira4, 5,
- Mariana Freitas6, 7, 8,
- Avelino Fraga9,
- Paulo Príncipe9,
- Carlos Lobato10,
- Francisco Lobo11,
- António Morais11,
- Vítor Silva11,
- José Sanches-Magalhães11,
- Jorge Oliveira11,
- Francisco Pina12,
- Anabela Mota-Pinto6, 7,
- Carlos Lopes2 and
- Rui Medeiros1, 2, 3
© Ribeiro et al; licensee BioMed Central Ltd. 2012
Received: 23 February 2012
Accepted: 2 April 2012
Published: 2 April 2012
Obesity is associated with prostate cancer aggressiveness and mortality. The contribution of periprostatic adipose tissue, which is often infiltrated by malignant cells, to cancer progression is largely unknown. Thus, this study aimed to determine if periprostatic adipose tissue is linked with aggressive tumor biology in prostate cancer.
Supernatants of whole adipose tissue (explants) or stromal vascular fraction (SVF) from paired fat samples of periprostatic (PP) and pre-peritoneal visceral (VIS) anatomic origin from different donors were prepared and analyzed for matrix metalloproteinases (MMPs) 2 and 9 activity. The effects of those conditioned media (CM) on growth and migration of hormone-refractory (PC-3) and hormone-sensitive (LNCaP) prostate cancer cells were measured.
We show here that PP adipose tissue of overweight men has higher MMP9 activity in comparison with normal subjects. The observed increased activities of both MMP2 and MMP9 in PP whole adipose tissue explants, likely reveal the contribution of adipocytes plus stromal-vascular fraction (SVF) as opposed to SVF alone. MMP2 activity was higher for PP when compared to VIS adipose tissue. When PC-3 cells were stimulated with CM from PP adipose tissue explants, increased proliferative and migratory capacities were observed, but not in the presence of SVF. Conversely, when LNCaP cells were stimulated with PP explants CM, we found enhanced motility despite the inhibition of proliferation, whereas CM derived from SVF increased both cell proliferation and motility. Explants culture and using adipose tissue of PP origin are most effective in promoting proliferation and migration of PC-3 cells, as respectively compared with SVF culture and using adipose tissue of VIS origin. In LNCaP cells, while explants CM cause increased migration compared to SVF, the use of PP adipose tissue to generate CM result in the increase of both cellular proliferation and migration.
Our findings suggest that the PP depot has the potential to modulate extra-prostatic tumor cells' microenvironment through increased MMPs activity and to promote prostate cancer cell survival and migration. Adipocyte-derived factors likely have a relevant proliferative and motile role.
KeywordsAdipose tissue Cell line Cell proliferation Cell tracking Obesity Periprostatic Prostate cancer
In recent years substantial evidence has been provided for the linkage between adipose tissue dysfunction and cancer progression [1, 2]. Excess accumulation of adipose tissue corresponds by definition to obesity, which has been associated with prostate cancer aggressiveness [3, 4].
In prostate cancer, the extra-capsular extension of cancer cells into the periprostatic (PP) fat is a pathological factor related with worst prognosis . It is now well established that the interactions between non-tumor cells in the microenvironment and the tumor cells are decisive of whether cancer cells progress towards metastasis or whether they remain dormant .
Prostate cancer cells generated within prostatic acini frequently infiltrate and even surpass the prostatic capsule, therefore interacting with the surrounding PP adipose tissue. Previous work showed that such adipose tissue has the potential to modulate prostate cancer aggressiveness, through the increased production of adipokines, namely interleukin 6 (IL-6) . Moreover, a recent report showed an association of PP adipose tissue thickness with prostate cancer severity .
Different studies have demonstrated the critical influence of adipose tissue-derived factors in cancer cells [9–11], including prostate tumor cells [12–14]. Together, these reports indicate that factors produced by adipose tissue, particularly adipocytes may stimulate the progression of cancer cells. However, to our knowledge, the influence of PP adipose tissue-derived factors on prostate cancer cells has not been exploited. Noteworthy, we previously observed that prostate cancer induced the increase of PP adipose metabolic activity, promoting a favorable environment for aggressive tumor biology .
To address these issues, we first studied the gelatinolytic profile of PP whole adipose tissue and its respective stromal-vascular fraction. Next, we used PP adipose tissue-derived conditioned medium to analyze in vitro its influence in proliferation and migration of prostate cancer cells.
Patients and collection of human PP adipose tissue
Men diagnosed with clinically localized prostate cancer or nodular prostatic hyperplasia (BPH) and eligible for retropubic radical prostatectomy or prostate surgery of nodular hyperplasia, without other major co-morbidities, were included in this study after informed consent agreement. The project was approved by the ethics committees of the participating Hospitals. Human anterior-lateral PP and pre-peritoneal visceral (VIS) samples of adipose tissue were collected during surgery and immediately processed.
Adipose tissue primary cultures and preparation conditioned media (CM)
PP and VIS adipose tissue fragments were processed to primary whole adipose tissue (explants) cultures using a modified protocol from Thalmann et al. . Briefly, after incubation of explants (0.3 g/mL) for 16 hours in DMEM/F12 (Gibco) medium, supplemented with biotin 16 μM (Sigma Aldrich), panthotenate 18 μM (Sigma Aldrich), ascorbate 100 μM (Sigma Aldrich), and 1% penicillin-streptomycin (Sigma Aldrich) (sDMEM/F12), fresh medium was added, and was referred to as time zero for time-course experiments. Explant cultures were maintained at 37°C and 5% CO2. After 48 hours, the undernatant was collected, centrifuged (20 000 g,3 minutes), aliquoted and stored at -80°C as explant conditioned medium (CM).
Other pieces of VIS and PP adipose tissue were incubated with collagenase (2 mg/mL) (Collagenase A, Roche) for 60 minutes at 37°C with agitation (120 rpm). After removal of adipocytes layer, the supernatant was discarded and the stromal-vascular fraction (SVF) cell pellet resuspended in sDMEM/F-12 with 10% Newborn Calf Serum (NCS) (Sigma Aldrich) and filtered through a 40 μm cell strainer (BD Falcon, BD Biosciences). Following erythrocyte lysis (Buffer EL, QIAgen), SVFs were resuspended and seeded (500 μL of cell suspension) in wells coated with 0.2% gelatin (Sigma Aldrich) in sDMEM/F-12 medium with 10% NCS. Stromal-vascular fraction cells were maintained at 37°C and 5% CO2. After 48 hours, fresh medium free from NCS was added. Forty-eight hours after this time-point CM was collected, centrifuged at 20 000 g for 3 minutes and the supernatant stored at -80°C as SVF CM.
Human PC-3 and LNCaP cell lines
PC-3 and LNCaP cell lines were obtained from the European Collection of Cell Cultures (ECCAC) and from the American Type Cell Culture (ATCC), respectively. Both cell lines were maintained in RPMI 1640 medium, supplemented with (%) L-glutamine and (%) Hepes (Gibco), 10% FBS (Gibco) and 1% PS (Sigma Aldrich), at 37°C with 5% CO2.
Cancer cells were seeded into 96-well plates (5×103 and 10×103 cells/well for PC-3 and LNCaP cells, respectively) and incubated for 24 hours in RPMI 1640 medium with 10% FBS. Next, supernatant was removed and new cell medium free from FBS, with (50% volume) or without (control) adipose tissue-derived conditioned medium was added to cancer cells.
Media was removed after 24 hours, and cells were stored at -80°C. Then, the pellet was solubilized in a lysis buffer supplemented with a DNA-binding dye (CyQUANT cell proliferation assay, Invitrogen). DNA content was evaluated in each well by fluorimetry at 480/535 nm using a standard curve previously generated for each cell type, after plotting measured fluorescence values in samples vs cell number, as determined from cell suspensions using a hemocytometer. Samples were performed in duplicate and the mean value used for analyses.
Gelatinolytic activities of MMP2 and MMP9 of supernatants from adipose tissue primary cultures were determined on substrate impregnated gels. Briefly, total protein from supernatants of primary cultures of adipose tissue (12 μg/well), were separated on 10% SDS-PAGE gels containing 0.1% gelatin (Sigma-Aldrich). After electrophoresis a 30 minutes washing step (2% Triton X-100) was performed, and gels were incubated 16-18 h at 37°C in substrate buffer (50 mM Tris-HCl, pH7.5, 10 mM CaCl2), to allow MMP reactivation. Next, gels were stained in a solution with Comassie Brilliant Blue R-250 (Sigma-Aldrich), 40% methanol and 10% acetic acid for 30 minutes. The correspondent MMP2 and MMP9 clear lysed bands were identified based on their molecular weight and measured with a densitometer (Quantity One, BioRad).
Cell tracking and analysis of cellular motility
For the time-lapse microscopy analysis (Zeiss Axiovert inverted-fluorescence microscope), exponentially growing cancer cells were seeded into 96-well plates at a density of 5×103 and 10×103 cells/well, for PC-3 and LNCaP, respectively. After 24 hours incubation in RPMI 1640 media supplemented with 10% FBS, supernatant was removed and new medium with (50% volume) or without (control, 0% CM) adipose tissue-derived conditioned medium, were added to cancer cells. At this time point the time-lapse experiment was started. A digital image of the field of interest was taken every 15 minutes for 24 hours, generating 85 frames that were arranged into sequences in .avi format (Zeiss Axiovert software). Two fields were selected in each well. The nucleus of each cell was followed using manual tracking from the first to the last frame and results recorded (Zeiss LSM Image Browser version 184.108.40.206).
We used mean speed (MS) and final relative distance to the origin (FRDO) as indicators to characterize cell trajectory and motility. Mean cell speed corresponds to the total distance covered during the experiment, divided by the duration of the experiment, which was considered to be representative of cell motility . To assess the distance the cell migrated since its origin to the end of the observation, we analyzed the linear distance between the initial and final cell position that allows the identification of the statistical trend of cells that randomly explore a large area.
Results are presented as mean ± S.E.M. Adequate adjustment of results per gram of adipose tissue were performed when comparing between the fractions and depots of adipose tissue. Normality was assessed by Kolmogorov-Smirnov test. Data for adipose tissue gelatinase activity, prostate cancer cell count and motility (final relative distance to origin), were log10-transformed to become normally distributed, whether adjusted or not to adipose tissue weight. One-way ANOVA with between groups' post-hoc Scheffe test or post-hoc Dunnett test, and the independent samples t-test, were used as appropriate. Whenever means for different groups wanted to be compared and normality conditions were not satisfied we used the Kruskal-Wallis test followed by Mann Whitney test once a significant P was obtained or only Mann Whitney test.
Statistical analyses were performed with SPSS 17.0. Significance was accepted at P less than 0.05. Details of the statistical analyses were included in each figure legend.
Gelatinase activity in conditioned medium from primary cultures of periprostatic (PP) adipose tissue explants, according to clinical and pathological characteristics
MMPs activity in supernatant of PP adipose tissue explant cultures (A.U.)
mean ± S.E.M.
mean ± S.E.M.
Age at diagnosis, yrsa
< median (65.1)
982.9 ± 154.8
498.9 ± 71.6
≥ median (65.1)
878.7 ± 111.2
558.3 ± 93.6
BMI, Kg/m2 b
895.4 ± 135.3
392.1 ± 48.3
960.3 ± 134.4
635.8 ± 87.5
958.6 ± 97.0
715.5 ± 142.6
PCa (< pT3)
873.8 ± 150.2
461.9 ± 68.1
1026.2 ± 169.8
511.0 ± 128.0
930.7 ± 189.5
477.0 ± 94.9
920.7 ± 148.6
479.1 ± 81.7
Prostate cancers frequently have a indolent course even if left without active treatment . However, clinically relevant disease with significant morbidity and mortality also occurs in a significant number of patients . The mechanisms responsible for this aggressive behavior remain elusive, albeit it is well established that the supporting tumor microenvironment has a decisive role in controlling prostate cancer growth, invasion and metastasis .
Cancer-implicated mammary and colonic fat pads [11, 21] are physically close to epithelial cells, whereas in prostate there is initially a capsular-like structure separating the PP fat from tumor cells. Nevertheless, frequently prostate tumors infiltrate the PP fat pad by transposing or infiltrating the physical barriers, resulting in immediate proximity to adipose tissue. Once extension beyond the capsule occurs, the PP adipose tissue-secreted factors, extracellular matrix components or direct cell-cell contact may influence the phenotypic behavior of malignant cells. Recent studies observed that PP adipose tissue thickness was linked to prostate cancer severity , while its secretory profile associated with advanced disease . In the present study, we found that PP adipose tissue-derived conditioned media may potentiate prostate cancer aggressiveness through modulation of metalloproteinases activity, and by promoting cancer cell proliferation and migration.
In tumors, cancer cells are not the only source of MMPs. In our study, MMP9 activity was significantly elevated in the PP adipose tissue of overweight/obese men (BMI ≥ 25 Kg/m2), implying excess body fat and the PP fat depot in the modulation of extra-capsular cancer cells' microenvironment. Concordantly, other studies found MMP9 to be positively correlated with BMI . Further research is warranted to uncover the effects of MMPs in association with distinct obesity grades. In our sample only two subjects presented BMI > 30 Kg/m2, limitating such approach.
Matrix metalloproteinases are proteolytic enzymes that regulate many cell mechanisms with prominence in cancer biology . Their expression in prostate tumors is related with disease progression and metastasis , whereas MMP9 was shown to increase growth factors bioavailability and to elicit epithelial-to-mesenchymal transition in tumor cells [25, 26], therefore promoting an aggressive phenotype. A recent report indicated that oesophageal tumors from obese patients express more MMP9 and that co-culture of VIS adipose tissue explants with tumor cells up-regulated MMP2 and MMP9 . Remains undetermined the influence of PP adipose tissue in the expression of MMPs by prostate cancer cells, which might further contribute towards an aggressive phenotype. Noteworthy, cancer-derived factors stimulate other surrounding cells, including adipose tissue cells, to synthesize MMPs .
In an effort to understand if the effects of PP adipose tissue extend to other aggressiveness characteristics, we used adipose tissue-derived CM to perform cell proliferation assays in prostate cancer cell lines. We found that CM from in vitro culture of adipose tissue explants stimulated the proliferation of hormone-refractory prostate cancer cells. Conversely, this media inhibited growth in hormone-sensitive cells.
It is well-established that adipose tissue secretes a wide array of molecules . These adipokines, exclusively or partially secreted by adipocytes or stromal-vascular fraction cells, are likely to have a role in modulating the risk of cancer progression [1, 29, 30]. Few studies examined the effect of adipocytes in prostate cancer cells growth [12, 13]. While a proliferative effect was observed in hormone-refractory PC-3 cells, these findings didn't replicate in LNCaP cells . In fact, the mitogenic and anti-apoptoptic effects of several adipokines, alone and combined, in prostate cancer cell growth (e.g. leptin, IL-6, insulin-like growth factor 1, IGF-1), seems to be limited to hormone-refractory prostate cancer cells [12, 31–34]. Previous studies also report on the suppression of LNCaP cell growth as response to adipokines (e.g. TNF-α, decreased expression of vascular endothelial growth factor, VEGF), not observed in hormone-refractory cells [13, 35–37].
Contrary to explants, CM from SVF cultures induces cancer cell proliferation, independently of cell line, except for the SVF from PP adipose tissue in PC-3 cells. Cells that constitute the SVF fraction of adipose tissue, where macrophages have a modulatory role, are known to secrete several angiogenic and antiapoptotic factors [38–40], which ultimately can impact prostate cancer cells growth. The lack of proliferative effect observed for the SVF fraction from PP adipose tissue may partially be due to the reported low number of macrophages in PP fat depot , diminishing the proliferative stimulus in prostate cancer cells.
Progression to an invasive and metastatic phenotype is responsible by prostate cancer mortality and morbidity. The increased cellular motility is another parameter associated with increased metastatic potential [41, 42]. By employing time-lapsed imaging, we found that factors produced by whole adipose tissue cultures (explants) increased significantly the migration speed and the final relative distance to origin of both PC-3 and LNCaP cells compared with control. Only the SVF fraction-derived CM effect in the final relative distance to origin of PC-3 cells, was not increased compared with control.
The mechanisms involved in tumor cell movement are far from fully elucidated, although various biophysical processes are considered to be involved : in order for a cell to move it must be polarized or have a sense of directionality; polarity is accompanied by 1) lamellipodia protrusion at the leading edge, followed by 2) detachment of the cell's rear end and subsequent 3) transcellular contractility. These mechanisms are modulated by the activation of several signaling pathways, such as PI3K, ERK/MAPK and c-Src tyrosine kinase , which are known downstream signals of adipokines . In fact, many adipokines (e.g. IGF-1, osteopontin, leptin, adiponectin, VEGF, thrombospondin, interleukin-8 and IL-6) have been shown to modulate different steps of cell motile behavior [44–56]. The repetitive and coordinated cycling of these processes results in productive locomotion of the cell. Several key pathways and molecules involved in this process can be induced by factors secreted by adipose tissue, hence supporting the increased motility we found in stimulated prostate cancer cells. Nevertheless, besides the influence of extrinsic factors, migratory tumor cells also present autocrine growth factor signaling systems . We disclose any potential bias from inadvertent selection using manual cell tracking analysis, urging careful interpretation of motility findings. Further studies using migration assays to extend and confirm our results are warranted.
Adipose tissue is a heterogeneous organ that consists of multiple cell types: adipocyte fraction, which contains lipid-loaded adipocytes, and stromal-vascular fraction, which includes preadipocytes, endothelial cells, fibroblasts, stem cells, macrophages and other immune cells . The fractions of adipose tissue differ in that while explants reflect an organotypic cell culture system of whole adipose tissue, the major characteristic of stromal-vascular fraction culture is the depletion of adipocytes and absence of extracellular matrix. In order to investigate which fraction influenced tumor cells, we cultured paired explants and stromal-vascular fraction cells. To allow comparison between depots and adipose tissue fractions, the cell count was adjusted per gram of adipose tissue. Interestingly, our findings showed that media from explants and PP adipose tissue depot presented the higher gelatinolytic activity per gram of adipose tissue, compared with SVF cultures- and VIS adipose tissue-derived media. Although the amount of MMP9 has been described to be higher in stromal-vascular fraction of adipose tissue compared with adipocytes , the latter have greater plasticity to increase MMPs expression when interacting with other cells in adipose tissue [22, 59]. The increased activity of metalloproteinases in CM from adipose tissue explants in culture compared with SVF, likely reflect the additive effect or interaction between cells of the stromal-vascular fraction plus adipocytes. We found that MMP2 activity was increased in PP versus VIS adipose tissue supernatants. Although there is no evidence of MMP2 role in adipose tissue/cancer cells crosstalk, recent findings suggest MMP2 is up-regulated in tumor cells co-cultured with adipose tissue explants and that its expression and activation is modulated by several adipokines (e.g. Wdnm1-like and visfatin) [27, 60, 61]. Additionally, other MMPs, notably MMP11, have been shown to be correlated with breast cancer-induced adipocyte's activated state [11, 62]. If confirmed, our findings may reveal a novel specific proteinase expression and activity pattern in PP adipose tissue favorable to prostate cancer progression.
In this study, proliferation was increased with CM from PP and VIS explants versus SVF CM in PC-3 cells, whereas LNCaP cells only proliferated significantly more with VIS explants compared to VIS SVF. As the highest proliferation was seen following stimulation with CM from explants we speculate adipocytes may be the main effectors. Other studies also found a proliferative effect of adipocytes in prostate cancer cells [12, 13]. Adipocytes add significantly to the proliferative effect in hormone-refractory prostate cancer cells, even though the adipokines responsible by these results have yet to be determined. Alternatively, since explants culture preserve the paracrine signals by maintaining the existing crosstalk among the different cell types , we hypothesize that the higher proliferative stimulus conferred by explants CM likely reflects a co-stimulatory and/or additive effect of adipokines produced by adipocytes and by the stromal vascular fraction cells.
Explants-derived CM, whether from VIS or PP origin exerted consistently, also across cell lines, an increased effect in migration speed and final relative distance to origin, when compared with SVF fraction. It is possible that explants CM, which reveal the secretory profile of adipocytes plus stromal-vascular cells, produce more motile factors and exclusive secretion of others (e.g. leptin and adiponectin), thereby resulting in increased total distance/mean speed and final relative distance to origin of prostate cancer cells.
The anatomical origin of adipose tissue accounts for increased gelatinolytic activity and different proliferative and migratory stimulus. CM from PP results in higher log10-transformed PC-3 and LNCaP cell count per gram of adipose tissue, only when SVF CM was used. Furthermore, adipose tissue from PP origin exerted the stronger motile effect (of both analyzed parameters) in PC-3 cells compared to VIS depot, independently of the culture type. In LNCaP cells only the PP explants-derived CM didn't impact the mean speed more than CM from VIS explants. These findings suggest that VIS and PP fat pads may have distinct relative cellular composition or are differently programmed to secrete molecules involved in the regulation of cell proliferation and motility. We recently found increased amount of adipose stem cells (CD34+/CD45-/CD31-/CD146-) in PP compared with VIS adipose tissue (Ribeiro R, unpublished observations).
Tumor cell progression depends on itself as well as on the surrounding microenvironment, which is able to influence proliferation, migration and metastatic behavior of tumor cells by modulating the extracellular matrix and growth factor production . If the tissues where tumor cells exist provide the missing extrinsic signals, then cells will proliferate and acquire an invasive phenotype, which may lead to metastasis. Whole periprostatic fat, not only stromal vascular fraction cells, seems to warrant the necessary factors to induce a specific microenvironment for prostate cancer tumor cells, which ultimately may result, as we found, in tumor cell survival, increased motility and availability of extracellular proteases. During cell migration, pericellular proteolysis of extracellular matrix is important for cell protrusion.
The increased production of MMPs found in PP adipose tissue can fuel invasive and metastatic behavior of PP fat-infiltrating prostate cancer cells.
In this study we found that PP adipose tissue-derived factors may potentiate prostate cancer aggressiveness through modulation of metalloproteinases activity, and by promoting cancer cell proliferation and motility. In addition, results indicate that factors secreted by whole periprostatic fat induce a favorable microenvironment for hormone-refractory prostate cancer tumor cells. These previously unrecognized findings suggest a role for PP adipose tissue in prostate cancer progression, and as a candidate explanatory mechanism to the causally invoked association between obesity and aggressive prostate cancer.
Body mass index
Nodular prostatic hyperplasia
Final relative distance to origin
Hormone-sensitive prostate cancer cell line
Hormone-refractory prostate cancer cell line
The authors acknowledge the Portuguese Foundation for Science and Technology (PTDC/SAL-FCF/71552/2006 and PTDC/SAU-ONC/112511/2009), the Research Centre on Environment, Genetics and Oncobiology of the University of Coimbra (CIMAGO 07/09), the Portuguese League Against Cancer - North Centre. This project was partially sponsored by an unrestricted educational grant for basic research in Molecular Oncology from Novartis Oncology Portugal. RR was the recipient of a PhD grant from POPH/FSE (SFRH/BD/30021/2006) and a UICC-ICRETT Fellowship (ICR/10/079/2010). MJ Oliveira is a Science 2007/FCT Fellow. Funders had no role in design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.
- Park J, Euhus DM, Scherer PE: Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression. Endocr Rev. 2011, 32: 550-570. 10.1210/er.2010-0030.PubMed CentralView ArticlePubMedGoogle Scholar
- van Kruijsdijk RC, van der Wall E, Visseren FL: Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 2009, 18: 2569-2578. 10.1158/1055-9965.EPI-09-0372.View ArticlePubMedGoogle Scholar
- Capitanio U, Suardi N, Briganti A, Gallina A, Abdollah F, Lughezzani G, Salonia A, Freschi M, Montorsi F: Influence of obesity on tumour volume in patients with prostate cancer. BJU Int. 2011, 109: 678-684.View ArticlePubMedGoogle Scholar
- Freedland SJ, Banez LL, Sun LL, Fitzsimons NJ, Moul JW: Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis. 2009, 12: 259-263. 10.1038/pcan.2009.11.View ArticlePubMedGoogle Scholar
- Cheng L, Darson MF, Bergstralh EJ, Slezak J, Myers RP, Bostwick DG: Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 1999, 86: 1775-1782. 10.1002/(SICI)1097-0142(19991101)86:9<1775::AID-CNCR20>3.0.CO;2-L.View ArticlePubMedGoogle Scholar
- Valastyan S, Weinberg RA: Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011, 147: 275-292. 10.1016/j.cell.2011.09.024.PubMed CentralView ArticlePubMedGoogle Scholar
- Finley DS, Calvert VS, Inokuchi J, Lau A, Narula N, Petricoin EF, Zaldivar F, Santos R, Tyson DR, Ornstein DK: Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol. 2009, 182: 1621-1627. 10.1016/j.juro.2009.06.015.View ArticlePubMedGoogle Scholar
- van Roermund JG, Hinnen KA, Tolman CJ, Bol GH, Witjes JA, Bosch JL, Kiemeney LA, van Vulpen M: Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients. BJU Int. 2011, 107: 1775-1779. 10.1111/j.1464-410X.2010.09811.x.View ArticlePubMedGoogle Scholar
- Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, et al: Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011, 17: 1498-1503. 10.1038/nm.2492.PubMed CentralView ArticlePubMedGoogle Scholar
- Schnabele K, Roser S, Rechkemmer G, Hauner H, Skurk T: Effects of adipocyte-secreted factors on cell cycle progression in HT29 cells. Eur J Nutr. 2009, 48: 154-161. 10.1007/s00394-009-0775-6.View ArticlePubMedGoogle Scholar
- Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al: Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011, 71: 2455-2465. 10.1158/0008-5472.CAN-10-3323.View ArticlePubMedGoogle Scholar
- Onuma M, Bub JD, Rummel TL, Iwamoto Y: Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem. 2003, 278: 42660-42667. 10.1074/jbc.M304984200.View ArticlePubMedGoogle Scholar
- Tokuda Y, Satoh Y, Fujiyama C, Toda S, Sugihara H, Masaki Z: Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction. BJU Int. 2003, 91: 716-720. 10.1046/j.1464-410X.2003.04218.x.View ArticlePubMedGoogle Scholar
- Somasundar P, Yu AK, Vona-Davis L, McFadden DW: Differential effects of leptin on cancer in vitro. J Surg Res. 2003, 113: 50-55. 10.1016/S0022-4804(03)00166-5.View ArticlePubMedGoogle Scholar
- Ribeiro RJ, Monteiro CP, Cunha VF, Azevedo AS, Oliveira MJ, Monteiro R, Fraga AM, Principe P, Lobato C, Lobo F, et al: Tumor Cell-educated Periprostatic Adipose Tissue Acquires an Aggressive Cancer-promoting Secretory Profile. Cell Physiol Biochem. 2012, 29: 233-240. 10.1159/000337604.View ArticlePubMedGoogle Scholar
- Thalmann S, Juge-Aubry CE, Meier CA: Explant cultures of white adipose tissue. Methods Mol Biol. 2008, 456: 195-199. 10.1007/978-1-59745-245-8_14.View ArticlePubMedGoogle Scholar
- Desbois D, Couturier E, Mackiewicz V, Graube A, Letort MJ, Dussaix E, Roque-Afonso AM: Epidemiology and genetic characterization of hepatitis A virus genotype IIA. J Clin Microbiol. 2010, 48: 3306-3315. 10.1128/JCM.00667-10.PubMed CentralView ArticlePubMedGoogle Scholar
- Albertsen PC, Hanley JA, Fine J: 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005, 293: 2095-2101. 10.1001/jama.293.17.2095.View ArticlePubMedGoogle Scholar
- Taichman RS, Loberg RD, Mehra R, Pienta KJ: The evolving biology and treatment of prostate cancer. J Clin Invest. 2007, 117: 2351-2361. 10.1172/JCI31791.PubMed CentralView ArticlePubMedGoogle Scholar
- Chung LW, Baseman A, Assikis V, Zhau HE: Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol. 2005, 173: 10-20. 10.1097/01.ju.0000141582.15218.10.View ArticlePubMedGoogle Scholar
- Notarnicola M, Miccolis A, Tutino V, Lorusso D, Caruso MG: Low levels of lipogenic enzymes in peritumoral adipose tissue of colorectal cancer patients. Lipids. 2012, 47: 59-63. 10.1007/s11745-011-3630-5.View ArticlePubMedGoogle Scholar
- Unal R, Yao-Borengasser A, Varma V, Rasouli N, Labbate C, Kern PA, Ranganathan G: Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. J Clin Endocrinol Metab. 2010, 95: 2993-3001. 10.1210/jc.2009-2623.PubMed CentralView ArticlePubMedGoogle Scholar
- Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2: 161-174. 10.1038/nrc745.View ArticlePubMedGoogle Scholar
- Lichtinghagen R, Musholt PB, Stephan C, Lein M, Kristiansen G, Hauptmann S, Rudolph B, Schnorr D, Loening SA, Jung K: mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue. Anticancer Res. 2003, 23: 2617-2624.PubMedGoogle Scholar
- Chakrabarti S, Patel KD: Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 2005, 31: 599-621. 10.1080/019021490944232.View ArticlePubMedGoogle Scholar
- Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, Lee MT: Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011, 102: 815-827. 10.1111/j.1349-7006.2011.01861.x.View ArticlePubMedGoogle Scholar
- Allott EH, Lysaght J, Cathcart MC, Donohoe CL, Cummins R, McGarrigle SA, Kay E, Reynolds JV, Pidgeon GP: MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation. Mol Carcinog. 2011, doi: 10.1002/mc.21840,Google Scholar
- Trayhurn P: Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand. 2005, 184: 285-293. 10.1111/j.1365-201X.2005.01468.x.View ArticlePubMedGoogle Scholar
- Mistry T, Digby JE, Desai KM, Randeva HS: Obesity and prostate cancer: a role for adipokines. Eur Urol. 2007, 52: 46-53. 10.1016/j.eururo.2007.03.054.View ArticlePubMedGoogle Scholar
- Ribeiro R, Lopes C, Medeiros R: The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis. 2006, 9: 19-24. 10.1038/sj.pcan.4500844.View ArticlePubMedGoogle Scholar
- Hoda MR, Popken G: Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells. BJU Int. 2008, 102: 383-388. 10.1111/j.1464-410X.2008.07534.x.View ArticlePubMedGoogle Scholar
- Chung TD, Yu JJ, Spiotto MT, Bartkowski M, Simons JW: Characterization of the role of IL-6 in the progression of prostate cancer. Prostate. 1999, 38: 199-207. 10.1002/(SICI)1097-0045(19990215)38:3<199::AID-PROS4>3.0.CO;2-H.View ArticlePubMedGoogle Scholar
- Mori S, Murakami-Mori K, Bonavida B: Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Biochem Biophys Res Commun. 1999, 257: 609-614. 10.1006/bbrc.1999.0515.View ArticlePubMedGoogle Scholar
- Iwamura M, Sluss PM, Casamento JB, Cockett AT: Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate. 1993, 22: 243-252. 10.1002/pros.2990220307.View ArticlePubMedGoogle Scholar
- Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T: Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. J Urol. 2000, 164: 800-805. 10.1016/S0022-5347(05)67318-1.View ArticlePubMedGoogle Scholar
- Chopra DP, Menard RE, Januszewski J, Mattingly RR: TNF-alpha-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett. 2004, 203: 145-154. 10.1016/j.canlet.2003.09.016.View ArticlePubMedGoogle Scholar
- Mistry T, Digby JE, Chen J, Desai KM, Randeva HS: The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun. 2006, 348: 832-838. 10.1016/j.bbrc.2006.07.139.View ArticlePubMedGoogle Scholar
- Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL: Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004, 109: 1292-1298. 10.1161/01.CIR.0000121425.42966.F1.View ArticlePubMedGoogle Scholar
- Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G, Zlabinger GJ, Stulnig TM: Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond). 2007, 31: 1420-1428. 10.1038/sj.ijo.0803632.View ArticleGoogle Scholar
- Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM: Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab. 2007, 293: E656-665. 10.1152/ajpendo.00127.2007.View ArticlePubMedGoogle Scholar
- Kharait S, Dhir R, Lauffenburger D, Wells A: Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochem Biophys Res Commun. 2006, 343: 848-856. 10.1016/j.bbrc.2006.03.044.View ArticlePubMedGoogle Scholar
- Mohler JL: Cellular motility and prostatic carcinoma metastases. Cancer Metastasis Rev. 1993, 12: 53-67. 10.1007/BF00689790.View ArticlePubMedGoogle Scholar
- Chen J: Multiple signal pathways in obesity-associated cancer. Obes Rev. 2011, 12: 1063-1070. 10.1111/j.1467-789X.2011.00917.x.View ArticlePubMedGoogle Scholar
- Wells A, Gupta K, Chang P, Swindle S, Glading A, Shiraha H: Epidermal growth factor receptor-mediated motility in fibroblasts. Microsc Res Tech. 1998, 43: 395-411. 10.1002/(SICI)1097-0029(19981201)43:5<395::AID-JEMT6>3.0.CO;2-T.View ArticlePubMedGoogle Scholar
- Desai B, Ma T, Chellaiah MA: Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion. J Biol Chem. 2008, 283: 13856-13866. 10.1074/jbc.M709401200.PubMed CentralView ArticlePubMedGoogle Scholar
- Subramaniam V, Vincent IR, Jothy S: Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells. Exp Mol Pathol. 2005, 79: 187-193. 10.1016/j.yexmp.2005.08.004.View ArticlePubMedGoogle Scholar
- Huang CY, Yu HS, Lai TY, Yeh YL, Su CC, Hsu HH, Tsai FJ, Tsai CH, Wu HC, Tang CH: Leptin increases motility and integrin up-regulation in human prostate cancer cells. J Cell Physiol. 2011, 226: 1274-1282. 10.1002/jcp.22455.View ArticlePubMedGoogle Scholar
- Tang CH, Lu ME: Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. Prostate. 2009, 69: 1781-1789. 10.1002/pros.21029.View ArticlePubMedGoogle Scholar
- Im E, Motiejunaite R, Aranda J, Park EY, Federico L, Kim TI, Clair T, Stracke ML, Smyth S, Kazlauskas A: Phospholipase Cgamma activation drives increased production of autotaxin in endothelial cells and lysophosphatidic acid-dependent regression. Mol Cell Biol. 2010, 30: 2401-2410. 10.1128/MCB.01275-09.PubMed CentralView ArticlePubMedGoogle Scholar
- Takahashi M, Ota S, Hata Y, Ogura K, Kurita M, Terano A, Nakamura T, Omata M: Constitutive expression of hepatocyte growth factor may maintain the sheet construction of gastric epithelial cells through facilitating actin-myosin contractile system. Biochem Biophys Res Commun. 1996, 219: 40-46. 10.1006/bbrc.1996.0178.View ArticlePubMedGoogle Scholar
- Kinoshita M, Shimokado K: Autocrine FGF-2 is responsible for the cell density- dependent susceptibility to apoptosis of HUVEC: A role of a calpain inhibitor-sensitive mechanism. Arterioscler Thromb Vasc Biol. 1999, 19: 2323-2329. 10.1161/01.ATV.19.10.2323.View ArticlePubMedGoogle Scholar
- Hoang MV, Nagy JA, Fox JE, Senger DR: Moderation of calpain activity promotes neovascular integration and lumen formation during VEGF-induced pathological angiogenesis. PLoS One. 2010, 5: e13612-10.1371/journal.pone.0013612.PubMed CentralView ArticlePubMedGoogle Scholar
- Taraboletti G, Roberts DD, Liotta LA: Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol. 1987, 105: 2409-2415. 10.1083/jcb.105.5.2409.View ArticlePubMedGoogle Scholar
- Wang JM, Taraboletti G, Matsushima K, Van Damme J, Mantovani A: Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem Biophys Res Commun. 1990, 169: 165-170. 10.1016/0006-291X(90)91449-3.View ArticlePubMedGoogle Scholar
- Ferry G, Tellier E, Try A, Gres S, Naime I, Simon MF, Rodriguez M, Boucher J, Tack I, Gesta S, et al: Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem. 2003, 278: 18162-18169. 10.1074/jbc.M301158200.PubMed CentralView ArticlePubMedGoogle Scholar
- Azare J, Doane A, Leslie K, Chang Q, Berishaj M, Nnoli J, Mark K, Al-Ahmadie H, Gerald W, Hassimi M, et al: Stat3 mediates expression of autotaxin in breast cancer. PLoS One. 2011, 6: e27851-10.1371/journal.pone.0027851.PubMed CentralView ArticlePubMedGoogle Scholar
- Geho DH, Bandle RW, Clair T, Liotta LA: Physiological mechanisms of tumor-cell invasion and migration. Physiology (Bethesda). 2005, 20: 194-200. 10.1152/physiol.00009.2005.View ArticleGoogle Scholar
- Khandekar MJ, Cohen P, Spiegelman BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011, 11: 886-895. 10.1038/nrc3174.View ArticlePubMedGoogle Scholar
- O'Hara A, Lim FL, Mazzatti DJ, Trayhurn P: Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium. Pflugers Arch. 2009, 458: 1103-1114. 10.1007/s00424-009-0693-8.View ArticlePubMedGoogle Scholar
- Wu Y, Smas CM: Wdnm1-like, a new adipokine with a role in MMP-2 activation. Am J Physiol Endocrinol Metab. 2008, 295: E205-215. 10.1152/ajpendo.90316.2008.PubMed CentralView ArticlePubMedGoogle Scholar
- Patel ST, Mistry T, Brown JE, Digby JE, Adya R, Desai KM, Randeva HS: A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis. Peptides. 2010, 31: 51-57. 10.1016/j.peptides.2009.10.001.View ArticlePubMedGoogle Scholar
- Andarawewa KL, Motrescu ER, Chenard MP, Gansmuller A, Stoll I, Tomasetto C, Rio MC: Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res. 2005, 65: 10862-10871. 10.1158/0008-5472.CAN-05-1231.View ArticlePubMedGoogle Scholar
- Toda S, Uchihashi K, Aoki S, Sonoda E, Yamasaki F, Piao M, Ootani A, Yonemitsu N, Sugihara H: Adipose tissue-organotypic culture system as a promising model for studying adipose tissue biology and regeneration. Organogenesis. 2009, 5: 50-56. 10.4161/org.5.2.8347.PubMed CentralView ArticlePubMedGoogle Scholar
- Sung SY, Chung LW: Prostate tumor-stroma interaction: molecular mechanisms and opportunities for therapeutic targeting. Differentiation. 2002, 70: 506-521. 10.1046/j.1432-0436.2002.700905.x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.